BizNews BizNews Radio

Inside story on SA's second Covid-19 vaccine trial: Wits vaccinology Professor Shabir Madhi

Loading player...
University of the Witwatersrand vaccinology expert Professor Shabir Madhi tells BizNews about how US drug company Novavax got to run a critical trial of its coronavirus vaccine. He shares the details of why this is a promising vaccine and picks up on the latest developments on Covid-19 vaccine trials in South Africa. Learn more about your ad choices. Visit megaphone.fm/adchoices
17 Aug 2020 4PM English South Africa Investing · Business News

Other recent episodes

BNC#8: Donald Mackay Q&A - The shocking truth about South Africa’s missing billions

Donald MacKay pulls back the curtain on 40 "slush funds" draining billions from South African taxpayers without oversight. From the opaque Black Industrialists Fund to the staggering R43 billion automotive subsidy, MacKay reveals why a Mercedes-Benz costs R300,000 more at home than in Manhattan. Discover how decentralisation, the BRICS alliance,…
8 Apr 9AM 33 min

Garth Brook: “Crocodile-eating” attorney needed to fight the Public Protector

In this interview with Chris Steyn, Garth Brook, the founder of River Rangers in Clarens, details his five-year battle with the Public Protector to ensure outstanding salaries are paid for a community-based programme that - at its height - employed over 180 people in one of the country’s most poverty-stricken…
8 Apr 9AM 16 min
All episodes